Your browser of choice has not been tested for use with If you have issues, please download one of the browsers listed here.

Insys Theraptcs Cmn (INSY) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart


See More
  • Market Capitalization, $K 730,620
  • Shares Outstanding, K 71,600
  • Annual Sales, $ 330,800 K
  • Annual Income, $ 58,480 K
  • 36-Month Beta 0.89
  • Price/Sales 2.65
  • Price/Book 2.71

Price Performance

See More
Period Period Low Period High Performance
8.95 +11.73%
on 12/22/16
11.22 -10.87%
on 01/05/17
+0.77 (+8.34%)
since 12/20/16
8.70 +14.94%
on 12/08/16
15.06 -33.60%
on 11/10/16
-1.85 (-15.61%)
since 10/20/16
8.70 +14.94%
on 12/08/16
23.20 -56.90%
on 01/22/16
-11.80 (-54.13%)
since 01/20/16

Most Recent Stories

More News
Lifshitz & Miller Law Firm Announces Investigation of Abeona Therapeutics Inc., Agile Therapeutics, Inc., Alere Inc., Floteck Industries, Inc., Insys Therapeutics Inc., MTS Systems Corporation, Ophthotech Corporation and Teekay Corporation

Abeona Therapeutics Inc. (ABEO)

Insys Therapeutics Announces Retirement of Dr. John N. Kapoor as CEO and Chairman; Appoints Dr. Santosh Vetticaden as Interim CEO and Steven Meyer as Chairman of the Board

Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") today announced that Dr. John N. Kapoor, its Founder, President and Chief Executive Officer ("CEO") and Chairman of the Company's Board...

Insys Therapeutics, Inc. to Present at J.P. Morgan 35th Annual Healthcare Conference

Insys Therapeutics, Inc. ("Insys" or "the Company") (NASDAQ:INSY) today announced that Santosh Vetticaden, MD, PhD, Senior Vice President and Chief Medical Officer, and Darryl Baker, Chief Financial Officer,...

INVESTOR ALERT: Investigation of Insys Therapeutics Announced by Holzer & Holzer

On December 8, 2016, six former executives of Insys Therapeutics, Inc. ("Insys" or the "Company") (NASDAQ: INSY) were arrested and charged with bribing doctors to unnecessarily prescribe...

Insys Therapeutics, Inc. Issues Statement Regarding Department of Justice Press Release

Insys Therapeutics, Inc. ("Insys" or "the Company") (NASDAQ:INSY) today issued the following statement regarding the Department of Justice / U.S. Attorney's Office / District of Massachusetts press release:...

Legal Cannabis Market is Gaining Attention

California is home to about 12 percent of Americans, and full legalization of cannabis in the state has been a major milestone for this young, still devolving industry. California will start issuing licenses...

Technical Reports on Biotech Equities -- Aurinia Pharma, Threshold Pharma, Regeneron Pharma, and INSYS Therapeutics

Today, monitors the most recent performances of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), Threshold Pharmaceuticals Inc. (NASDAQ: THLD), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN),...

Cannabis Companies Press on in Exploding Legal Marijuana Market

CORAL SPRINGS, Florida, November 29, 2016 /PRNewswire/ --

Cannabis Companies Press on in Exploding Legal Marijuana Market

As the legal marijuana industry continues to see high levels of competition within the marketplace, Cannabis operators in the sector are executing strategies by developing innovative services and products...

Legal Cannabis Market Expects Growth - California was one of the four states where cannabis for recreational use has voted in favor, and is now legal. California is the largest market for the legal cannabis industry...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and...

See More

Support & Resistance

2nd Resistance Point 10.67
1st Resistance Point 10.34
Last Price 10.00
1st Support Level 9.81
2nd Support Level 9.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.